Latest News - Roper Technologies
Top Corporates Hub
Roper Technologies
What's going on in today's session: S&P500 movers
23.07.2026 16:35
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.
Roper Technologies Q2 Earnings Call Highlights
23.07.2026 15:07
Roper Technologies (NASDAQ:ROP) reported second-quarter results that topped its internal expectations and raised its full-year outlook, citing solid organic growth, continued strong retention and accelerating artificial intelligence product development across its portfolio. President and Chief Exec
Stock Market Today: Dow Jones Index Falls 400 Points As Alphabet, Tesla Dive On Earnings News (Live Coverage)
23.07.2026 13:48
Stock Market Today: The Dow Jones index dropped 400 points Thursday as Alphabet and Tesla stock dived on earnings. Oil prices jumped.
Roper Technologies (ROP) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
23.07.2026 13:30
The headline numbers for Roper Technologies (ROP) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Stocks making the biggest moves midday: Alphabet, Tesla, Amazon, Southwest Airlines & more
23.07.2026 13:04
Here are some of the companies making headlines in midday trading.
DAT’s Convoy Platform integrates with Tai TMS to automate carrier matching to freight brokers
23.07.2026 13:00
PORTLAND, Ore. and HUNTINGTON BEACH, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- DAT Freight & Analytics and Tai Software today announced an integration that lets freight brokers using Tai’s transportation management system (TMS) access Convoy Platform’s automated freight matching technology directly within Tai TMS. The integration helps brokers cover more freight with less manual effort while preserving the systems and processes their teams rely on. “Our goal is to make Convoy Platform available
Roper Technologies (NASDAQ:ROP) Rises After Q2 Beat and Raised Guidance, Showing Strong Growth Momentum
23.07.2026 12:24
Roper Technologies matched Q2 estimates and raised 2026 guidance, driving shares up 6.4% in pre-market trading on strong cash flow and aggressive buybacks.
Roper Technologies (ROP) Tops Q2 Earnings and Revenue Estimates
23.07.2026 12:15
Roper Technologies (ROP) delivered earnings and revenue surprises of +1.70% and +0.50%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Roper Technologies, Inc. 2026 Q2 - Results - Earnings Call Presentation
23.07.2026 11:32
2026-07-23. The following slide deck was published by Roper Technologies, Inc.
Roper Technologies announces second quarter financial results
23.07.2026 10:55
Increases full year guidanceSARASOTA, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) reported financial results for the second quarter ended June 30, 2026. Second quarter 2026 highlights Revenue increased 9% to $2.11 billion; organic revenue was +5% and acquisition contribution was +3%GAAP DEPS increased 233% to $11.62; adjusted DEPS increased 10% to $5.38GAAP operating cash flow increased 16% to $469 million; adjusted free cash flow increased 11% to $447 millionR
Full Transcript: Roper Techs Q2 2026 Earnings Call
23.07.2026 09:41
On Thursday, Roper Techs (NASDAQ:ROP) discussed second-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings call transcripts and
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
23.07.2026 08:06
Gainers Domo (NASDAQ:DOMO) shares moved upwards by 41.0% to $4.44 during Thursday's pre-market session. The company's market cap stands at $142.2 million. NVE (NASDAQ:NVEC) shares rose 21.13% to $105.0. The
Roper Technologies Raises FY2026 GAAP EPS Guidance from $16.67-$16.92 to $24.78-$24.93 vs $16.88 Est
23.07.2026 06:56
Roper Technologies (NASDAQ:ROP) raises FY2026 GAAP EPS guidance from $16.67-$16.92 to $24.78-$24.93 vs $16.88 analyst estimate..
Roper Technologies Sees Q3 GAAP EPS $4.07-$4.12 vs $4.44 Est
23.07.2026 06:56
Roper Technologies (NASDAQ:ROP) is looking for Q3 GAAP EPS of $4.07-$4.12 vs $4.44 analyst estimate..
Roper Technologies Sees Q3 Adj EPS $5.75-$5.80 vs $5.66 Est
23.07.2026 06:56
Roper Technologies (NASDAQ:ROP) is looking for Q3 Adj EPS of $5.75-$5.80 vs $5.66 analyst estimate..
Roper Technologies Raises FY2026 Adj EPS Guidance from $21.80-$22.05 to $22.15-$22.30 vs $21.73 Est
23.07.2026 06:56
Roper Technologies (NASDAQ:ROP) raises FY2026 Adj EPS guidance from $21.80-$22.05 to $22.15-$22.30 vs $21.73 analyst estimate..
Roche (SWX:ROP) Appoints Dan Malarek To Lead Its North America Diagnostics Business
23.07.2026 01:10
Roche Holding (SWX:ROP) has appointed Dan Malarek as President and CEO of Roche Diagnostics North America. The leadership change affects one of Roche’s key operating segments within its broader healthcare business. Malarek previously led Foundation Medicine, a Roche affiliate focused on precision medicine and genomic insights. Roche Holding’s diagnostics arm sits at the center of how the company supports hospitals, labs, and clinicians with testing platforms and data driven tools. As...
Curious about Roper Technologies (ROP) Q2 Performance? Explore Wall Street Estimates for Key Metrics
21.07.2026 13:15
Beyond analysts' top-and-bottom-line estimates for Roper Technologies (ROP), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.
Roche Holding (SWX:ROP) Could Be 7% Undervalued On Pipeline Momentum
16.07.2026 12:20
Roche Holding (SWX:ROP) is back in focus after the US Food and Drug Administration granted Priority Review to its supplemental Biologics License Application for Gazyva/Gazyvaro in primary membranous nephropathy, highlighting late stage pipeline momentum. See our latest analysis for Roche Holding. Roche Holding’s CHF330.2 share price follows a 5.33% 90 day share price return and a 32.83% 1 year total shareholder return, suggesting recent FDA and diagnostics news is feeding into building...
Roche (SWX:ROG) Stock Could Trade At A Discount Despite Its 35% Run
16.07.2026 08:14
Roche Holding shares have delivered a 35.0% return over the past three years, and the stock now screens as undervalued on market multiples with a high value score, raising the question of whether the current price still offers a margin of safety. A 35.0% gain over three years suggests Roche Holding has already rewarded patient shareholders, so fresh buyers need to consider how much of the story is already reflected in the price. Positive late stage data for oncology and kidney disease...